TYBOURNE CAPITAL MANAGEMENT (HK) LTD - RENEO PHARMACEUTICALS INC ownership

RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 40 filers reported holding RENEO PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
TYBOURNE CAPITAL MANAGEMENT (HK) LTD ownership history of RENEO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$2,058,000
-67.9%
700,000
-6.7%
0.12%
-35.8%
Q4 2021$6,413,000
+14.8%
750,0000.0%0.19%
+34.8%
Q3 2021$5,588,000
-20.1%
750,0000.0%0.14%
-4.1%
Q2 2021$6,998,000750,0000.15%
Other shareholders
RENEO PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
RiverVest Venture Management LLC 2,409,220$8,071,0009.37%
Abingworth LLP 2,073,957$6,948,0002.38%
Aisling Capital Management LP 886,075$2,968,0001.97%
NEA Management Company, LLC 4,786,921$16,036,0000.80%
Novo Holdings A/S 3,430,377$11,492,0000.55%
Ikarian Capital, LLC 155,819$521,0000.10%
Rock Springs Capital Management LP 1,143,185$3,830,0000.10%
Ergoteles LLC 37,640$126,0000.00%
MAI Capital Management 63,210$212,0000.00%
RBF Capital, LLC 14,536$49,0000.00%
View complete list of RENEO PHARMACEUTICALS INC shareholders